Piper Sandler Maintains Overweight on BXP, Lowers Price Target to $72

Benzinga Newsdesk www.benzinga.com Negative 69.8%

Neg 69.8% Neu 0% Pos 0%

Piper Sandler analyst Alexander Goldfarb maintains BXP (NYSE:BXP) with a Overweight and lowers the price target from $88 to $72.